Detalhe da pesquisa
1.
[111In]In-CP04 as a novel cholecystokinin-2 receptor ligand with theranostic potential in patients with progressive or metastatic medullary thyroid cancer: final results of a GRAN-T-MTC Phase I clinical trial.
Eur J Nucl Med Mol Imaging
; 50(3): 892-907, 2023 02.
Artigo
em Inglês
| MEDLINE | ID: mdl-36334104